Engineering molecules with artificial intelligence C h a i p o w e r s d r u g d i s c o v e r y p r o g r a m s a t t h e w o r l d ' s l e a d i n g p h a r m a c e u t i c a l c o m p a n i e s . C h a i p o w e r s d r u g d i s c o v e r y p r o g r a m s a t t h e w o r l d ’ s l e a d i n g p h a r m a c e u t i c a l c o m p a n i e s . Announcing our Series C We've raised $400M of new funding to accelerate our work at Chai. Read Announcement Announcing our Series C We've raised $400M of new funding to accelerate our work at Chai. Read Announcement Chai Discovery builds the computer-aided design suite for molecules. O u r m o d e l s l e a r n t h e u n d e r l y i n g f o u n d a t i o n s o f b i o c h e m i c a l s t r u c t u r e a n d i n t e r a c t i o n , e n a b l i n g s c i e n t i s t s t o d e s i g n n e w m e d i c i n e s o n t h e c o m p u t e r . W i t h C h a i , t h e w o r l d ' s l e a d i n g l i f e s c i e n c e s c o m p a n i e s m o v e f a s t e r a n d p u r s u e t a r g e t s t h a t o t h e r m e t h o d s c a n ' t r e a c h . NOVARTIS Chai Discovery announces collaboration with Novartis to advance AI-Driven antibody discovery NOVARTIS Chai Discovery announces collaboration with Novartis to advance AI-Driven antibody discovery PFIZER Chai Discovery announces license agreement with Pfizer to accelerate drug discovery with AI PFIZER Chai Discovery announces license agreement with Pfizer to accelerate drug discovery with AI ELI LILLY With new AI deal, Eli Lilly and Chai Discovery kick off a 'year of deployment' in pharma ELI LILLY With new AI deal, Eli Lilly and Chai Discovery kick off a 'year of deployment' in pharma argenx Chai Discovery Enters Into Collaboration Agreement With argenx to Advance AI-Driven Immunology Breakthroughs argenx Chai Discovery Enters Into Collaboration Agreement With argenx to Advance AI-Driven Immunology Breakthroughs Research Update Drug-like antibody design against challenging targets with atomic precision Research Update Drug-like antibody design against challenging targets with atomic precision Read More Chai Discovery builds the computer-aided design suite for molecules. O u r m o d e l s l e a r n t h e p r i n c i p l e s o f b i o l o g i c a l s t r u c t u r e a n d i n t e r a c t i o n , a n d d e s i g n n e w m o l e c u l e s f r o m s c r a t c h . W i t h C h a i , t h e w o r l d ’ s l e a d i n g l i f e s c i e n c e s c o m p a n i e s m o v e f a s t e r a n d p u r s u e t a r g e t s t h a t o t h e r m e t h o d s c a n ’ t r e a c h . NOVARTIS Chai Discovery announces collaboration with Novartis to advance AI-Driven antibody discovery PFIZER Chai Discovery announces license agreement with Pfizer to accelerate drug discovery with AI ELI LILLY With new AI deal, Eli Lilly and Chai Discovery kick off a 'year of deployment' in pharma argenx Chai Discovery Enters Into Collaboration Agreement With argenx to Advance AI-Driven Immunology Breakthroughs Research Update Drug-like antibody design against challenging targets with atomic precision Read More We’re building a future where new medicines can be designed with the precision and speed of modern engineering. Join us and contribute to one of the most meaningful challenges in AI. Open Roles © 2026 All rights reserved . Terms of Service Privacy Policy Press Contact Us © 2026 All rights reserved . Terms of Service Privacy Policy Press Contact Us